ResearcherMersin Şehir Eğitim ve Araştırma HastanesiActive in the last 2 years
Ahmet Küçük
Matched on ORCID iD 0000-0002-5361-364X; OpenAlex author ID A5021976790.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 1, last author 0)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 3
2022: 1 paper · 2023: none · 2024: 1 paper
Papers 2
- High Systemic Immune-Inflammation Index Values Before Treatment Predict Poor Pancreatic Cancer Outcomes After Definitive Chemoradiotherapy. Co-author DOI 10.1177/11795549241298552↗
- High Measures of Pre-Chemoradiotherapy Platelet-to-Albumin Ratio Indicates Poor Prognosis in Locally Advanced Pancreatic Cancer Patients. First author DOI 10.2147/tcrm.s359553↗
Closest collaborators
The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Uğur Selek · 2 shared papers, 2022–2024
- Paper High Systemic Immune-Inflammation Index Values Before Treatment Predict Poor Pancreatic Cancer Outcomes After Definitiv… DOI 10.1177/11795549241298552↗
- Paper High Measures of Pre-Chemoradiotherapy Platelet-to-Albumin Ratio Indicates Poor Prognosis in Locally Advanced Pancreati… DOI 10.2147/tcrm.s359553↗
- Erkan Topkan · 2 shared papers, 2022–2024
- Paper High Systemic Immune-Inflammation Index Values Before Treatment Predict Poor Pancreatic Cancer Outcomes After Definitiv… DOI 10.1177/11795549241298552↗
- Paper High Measures of Pre-Chemoradiotherapy Platelet-to-Albumin Ratio Indicates Poor Prognosis in Locally Advanced Pancreati… DOI 10.2147/tcrm.s359553↗
- Berrin Pehlivan · 2 shared papers, 2022–2024
- Paper High Systemic Immune-Inflammation Index Values Before Treatment Predict Poor Pancreatic Cancer Outcomes After Definitiv… DOI 10.1177/11795549241298552↗
- Paper High Measures of Pre-Chemoradiotherapy Platelet-to-Albumin Ratio Indicates Poor Prognosis in Locally Advanced Pancreati… DOI 10.2147/tcrm.s359553↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.